Arcosa, Inc.
ACA
$87.01
$1.681.97%
| Weiss Ratings | ACA - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Good | |||
| Risk Index | Fair | |||
| Risk Grade | C | |||
| Reward Grade | B | |||
| Rating Factors | ACA - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Weak | |||
| Growth Index | Good | |||
| Efficiency Index | Good | |||
| Solvency Index | Excellent | |||
| Total Return Index | Fair | |||
| Volatility Index | Fair | |||
| Beta / Standard Deviation | ACA - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.80 | |||
| Price History | ACA - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -1.42% | |||
| 30-Day Total Return | -6.32% | |||
| 60-Day Total Return | -3.20% | |||
| 90-Day Total Return | -5.39% | |||
| Year to Date Total Return | -7.63% | |||
| 1-Year Total Return | 29.99% | |||
| 2-Year Total Return | 42.95% | |||
| 3-Year Total Return | 18.24% | |||
| 5-Year Total Return | 148.38% | |||
| 52-Week High % Change | -13.89% | |||
| 52-Week Low % Change | 32.84% | |||
| Price | ACA - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $89.07 | |||
| 52-Week Low Price | $57.74 | |||
| 52-Week Low Price (Date) | Apr 26, 2023 | |||
| 52-Week High Price (Date) | Feb 23, 2024 | |||
| Valuation | ACA - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 3.68B | |||
| Enterprise Value | 4.19B | |||
| Price/Earnings (TTM) | 23.31 | |||
| Earnings Per Share (TTM) | 3.25 | |||
| Earnings Per Share Growth | -35.51% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 1.60 | |||
| Price/Book (Q) | 1.58 | |||
| Enterprise Value/Revenue (TTM) | 1.83 | |||
| Price | $75.78 | |||
| Enterprise Value/EBITDA (TTM) | 12.35 | |||
| Enterprise Value/EBIT | 23.13 | |||
| Market Cap Category | Mid Cap | |||
| Dividends and Shares | ACA - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 48.70M | |||
| Dividend Yield | 0.26% | |||
| Div. Per Share (Most Recent) | $0.05 | |||
| Dividend Per Share (TTM) | $0.20 | |||
| Payout Ratio (TTM) | 6.16% | |||
| Dividend Per Share (Most Recent) | $0.05 | |||
| Company Info | ACA - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 972 942 6500 | |||
| Address | 500 North Akard Street Dallas, TX 75201 | |||
| Website | www.arcosa.com | |||
| Country | United States | |||
| Year Founded | 2018 | |||
| Profitability | ACA - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 7.91% | |||
| Profit Margin | 6.89% | |||
| Management Effectiveness | ACA - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 3.30% | |||
| Return on Equity | 7.05% | |||
| Income Statement | ACA - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 2.31B | |||
| Total Revenue (TTM) | 2.31B | |||
| Revenue Per Share | $47.39 | |||
| Gross Profit (TTM) | 443.80M | |||
| EBITDA (TTM) | 342.20M | |||
| EBIT (TTM) | 182.70M | |||
| Net Income (TTM) | 159.20M | |||
| Net Income Avl. to Common (TTM) | 159.20M | |||
| Total Revenue Growth (Q YOY) | 16.37% | |||
| Earnings Growth (Q YOY) | -82.47% | |||
| EPS Diluted (TTM) | 3.25 | |||
| EPS Diluted Growth (Q YOY) | -82.56% | |||
| Balance Sheet | ACA - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 104.80M | |||
| Cash Per Share (Q) | $2.15 | |||
| Total Current Assets (Q) | 912.00M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 2.33B | |||
| Current Ratio (Q) | 2.115 | |||
| Book Value Per Share (Q) | $47.98 | |||
| Total Assets (Q) | 3.58B | |||
| Total Current Liabilities (Q) | 431.20M | |||
| Total Debt (Q) | 606.80M | |||
| Total Liabilities (Q) | 1.25B | |||
| Total Common Equity (Q) | 2.33B | |||
| Cash Flow | ACA - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -285.80M | |||
| Cash from Financing (TTM) | -30.80M | |||
| Net Change in Cash (TTM) | -55.60M | |||
| Levered Free Cash Flow (TTM) | 35.43M | |||
| Cash from Operations (TTM) | 261.00M | |||
